// App-Quantinova.ai

: Advanced glycation end-products and chronic inflammation in adult survivors of childhood leukemia treated with hematopoietic stem cell transplantation: possible role in the pathogenesis of cardiovascular late effects

Researchers

Presenter

  • Francesco Felicetti

Principal Investigators

  • Alessia Sofia Cento

  • Paolo Fornengo

  • Maurizio Cassader

  • Raffaella Mastrocola

  • Fabrizio D’Ascenzo

  • Fabio Settanni

  • Andrea Benso

  • Emanuela Arvat

  • Massimo Collino

  • Franca Fagioli

  • Manuela Aragno

  • Enrico Brignardello

Medical Centers

  • Transition Unit for Childhood Cancer Survivors, AOU Citt della Salute e della Scienza, Turin, Italy

  • Department of Neuroscience, University of Turin, Torino, Italy

  • General Pathology Unit, Department of Clinical and Biological Sciences, University of Turin, Turin, Italy

  • Department of Medicine, Città della Salute e della Scienza Hospital, Turin, Italy

  • Division of Cardiology, Città della Salute e della Scienza Hospital, Turin, Italy

  • Division of Endocrinology, Diabetology and Metabolism, Città della Salute e della Scienza Hospital, Turin, Italy

  • Division of Cardiology, Città della Salute e della Scienza Hospital, Turin, Italy

  • Dept. of Drug Science and Technology, University of Torino, Torino, Italy

  • Division of Paediatric Onco-Haematology, Stem Cell Transplantation and Cellular Therapy, Città della Salute e della Scienza Hospital, Turin, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Solid malignancies

Biomarkers

  • Apolipoprotein B

  • Breakpoint Cluster Region

  • Proto-oncogene tyrosine-protein kinase ROS

  • Glutathione

  • Interleukin 17A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved